Bexion Pharmaceuticals, Inc.

Covington, KY

UEI
HJPDQTK95NS8
CAGE
4GFU7
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
632 Russell St, Covington, KY 41011, USA
Website
bexionpharma.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sapc-dops nanovesicles for treating glioblastoma multiforme R43CA136017 National Institutes of Health $273,138
A novel biotherapeutic treatment for pancreatic cancer R43CA117283 National Institutes of Health $99,965
Sapc-dops nanovesicles for treating glioblastoma multiforme R44CA136017 National Institutes of Health $4,368,595
A novel biotherapeutic treatment for prostate cancer R43CA130228 National Institutes of Health $145,306

Quick answers

Is Bexion Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Bexion Pharmaceuticals, Inc.'s SAM.gov registration is active through August 19, 2027.

What is Bexion Pharmaceuticals, Inc.'s most recent federal award?

Bexion Pharmaceuticals, Inc.'s most recent federal grant award is Sapc-dops nanovesicles for treating glioblastoma multiforme (R43CA136017), from National Institutes of Health, on September 25, 2008.

On GovTribe

See Bexion Pharmaceuticals, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login